Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore additional resources to study natural toxins, pollutants including PFAS and 6-PPD-Q, and their biological effects.
ENVIRONMENTAL TOXICOLOGY TOOLS & SERVICESMethylisothiazolinone (MI) is an isothiazolinone-derived biocide.1,2 It is active against Gram-positive and Gram-negative bacteria, as well as fungi, when used in combination with methylchloroisothiazolinone (MCI) with MIC values of 0.0002, 0.0002, 0.00005, and 0.00005% (w/w) for S. aureus, P. aeruginosa, A. niger, and C. albicans, respectively.2 Methylisothiazolinone (50 µM) also inhibits c-Src autophosphorylation in a cell-free assay.3 It reduces cell viability percentage in isolated embryonic rat cortical neurons when used at a concentration of 3 µM and decreases neurite length at 1 µM. MI, alone and as a mixture with MCI, can elicit contact sensitization.4 Formulations containing methylisothiazolinone have been used in the control of bacteria, fungi, and algae in residential use and industry, as well as a preservative in personal care products.
WARNING This product is not for human or veterinary use.
1. Importance of porins for biocide efficacy against Mycobacterium smegmatis. Appl. Environ. Microbiol. 77(9), 3068-3073 (2011).
2. Low-
3. Methylisothiazolinone, a neurotoxic biocide, disrupts the association of SRC family tyrosine kinases with focal adhesion kinase in developing cortical neurons. J. Pharmacol. Exp. Ther. 317(3), 1320-1329 (2006).
4. Increasing trend of sensitization to methylchloroisothiazolinone/methylisothiazolinone (MCI/MI). An. Bras. Dermatol. 89(3), 527-528 (2014).